Scottish Medicines Consortium recommends Merck’s Tepmetko
18th January 2023 Uncategorised 0Therapy is the first oral MET inhibitor treatment option for certain advanced NSCLC adult patients More: Scottish Medicines Consortium recommends Merck’s Tepmetko Source: News
read more